Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Spectral enrolled 13+ patients per month!

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Apr 14, 2023 1:19pm

206 Views

Post# 35395572

RE:RE:Spectral enrolled 13+ patients per month!

Yes, it took them years, tens of millions of sharholder's investments, and absurd dillution to figure out what could have been worked out on the back of a napkin.

As they knew "Actual Enrollment Rate Averages" from the EUPHRATES trial it would have been pretty simple to then adjust the number of sites and see the effect on the timeline.

So many times they've have told us how much they learned from the EUPHRATES trial.

Shareholders are taking the brunt from what they clearly did not learn.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal